Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8

LC16m8 is a live, attenuated, cell-cultured smallpox vaccine that was developed and licensed in Japan in the 1970s, but was not used in the campaign to eradicate smallpox. In the early 2000s, the potential threat of bioterrorism led to reconsideration of the need for a smallpox vaccine. Subsequently...

Descripción completa

Detalles Bibliográficos
Autores principales: Eto, Akiko, Saito, Tomoya, Yokote, Hiroyuki, Kurane, Ichiro, Kanatani, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533910/
https://www.ncbi.nlm.nih.gov/pubmed/26319072
http://dx.doi.org/10.1016/j.vaccine.2015.07.111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533910/
https://www.ncbi.nlm.nih.gov/pubmed/26319072
http://dx.doi.org/10.1016/j.vaccine.2015.07.111

Ejemplares similares